From Northwestern’s Center for Synthetic Biology:

Translating exciting discoveries into next-generation technologies fuels the mission of the Center for Synthetic Biology (CSB) at Northwestern. Since its inception in 2016, the CSB has produced several start-up companies that have contributed to the University’s entrepreneurial ecosystem. One example is Opera Bioscience, a promising new startup cofounded by Danielle Tullman-Ercek, Professor of Chemical and Biological Engineering. Last year, Opera Bioscience joined Northwestern’s multimillion-dollar technology accelerator Querrey InQbation Lab to hasten the commercialization of its proprietary technology.

Read the rest of the article here.